HotopfM, ChidgeyJ, Addington-HallJ, LyKL: Depression in advanced disease: A systematic review Part 1: Prevalence and case finding. Palliat Med, 2002; 16:81–97.
2.
BlockSD: Assessing and managing depression in the terminally ill patient. Ann Intern Med, 2000; 132:209–218.
3.
WoodsSW, TesarGE, MurrayGB, CassemNH: Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry, 1986; 47:12–15.
4.
OlinJ, MasandP: Psychostimulants for depression in hospitalized cancer patients. Psychosomatics, 1996; 37:57–62.
5.
LavretskyH, ReinliebM, et al.: Citalopram, methylphenidate, or their combination in geriatric depression: A randomized, double-blind, placebo-controlled trial. Am J Psychiatry, 2015; 172:561–569.
6.
JanberidzeE, HjermstadMJ, BrunelliC, et al.; EURO IMPACT: The use of antidepressants in patients with advanced cancer: Results from an international multicentre study. Psychooncology, 2014; 23:1096–1102.
7.
Lloyd WilliamsM, FriedmanT, RuddN: A survey of antidepressant prescribing in the terminally ill. Palliat Med, 1999; 13:243–248.
8.
RaynerL, PriceA, HotopfM, HigginsonIJ: Expert opinion on detecting and treating depression in palliative care: A Delphi study. BMC Palliat Care, 2011; 10:10.
9.
SanchezC, ReinesEH, MontgomerySA: A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?. Int Clin Psychopharmacol, 2014; 29:185–196.
10.
PreskornSH: Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med, 1993; 94:S2–S12.
11.
MarksDM, ShahMJ, PatkarAA, et al.: Serotonin-norepinephrine reuptake inhibitors for pain control: Premise and promise. Curr Neuropharmacol, 2009; 7:331–336.
12.
PiccoloJ, KolesarJ: Prevention and treatment of chemotherapy-induced peripheral neuropathy. Am J Health Syst Pharm, 2014; 71:19–25.
13.
TheobaldDE, KirshKL, HoltsclawE, et al.: An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage, 2002; 23:442–447.
14.
ShopsinB: Bupropion: A new clinical profile in the psychobiology of depression. J Clin Psychiatry, 1983; 44:140–142.
15.
MathewSJ, ShahA, LapidusK, et al.: Ketamine for treatment-resistant unipolar depression: Current evidence. CNS Drugs, 2012; 26:189–204.
16.
ThaseME, TrivediMH, et al.: Examining the efficacy of adjunctive aripiprazole in major depressive disorder: A pooled analysis of 2 studies. Prim Care Companion J Clin Psychiatry, 2008; 10:440–447.
